HemCon Medical Technologies is a manufacturer of medical devices for the civilian and armed forces markets. It develops chitosan-based bandages under the trade name of HemCon to severe arterial bleeding. The company has commercial operations in Ireland, England, Germany and the Czech Republic. HemCon Medical Technologies products are utilized for wound care practices in hospital, dental and clinical settings. Its wholly owned subsidiary, Synpart Limited, designs, manufactures and distributes private-label and branded oral care products for customers worldwide. The company also participates in a variety of nonprofit programs. HemCon Medical Technologies has achieved ISO 13485 certification. In addition, it has introduced the Mycosinate technology, which provides the controlled release of antimicrobial agents to fight against infections.
Partial Data by Infogroup (c) 2024. All rights reserved.
Partial Data by Foursquare.